[1]
|
Ortman, J.M., Velkoff, V.A. and Hogan, H. (2014) An Aging Nation: The Older Population in the United States. In: Current Population Reports, U.S. Census Bureau, Washington DC, 25-1140.
|
[2]
|
Kontis, V., Bennett, J.E., Mathers, C.D., et al. (2017) Future Life Expectancy in 35 Industrialised Countries: Projections with a Bayesian Model Ensemble. The Lancet, 389, 1323-1335. https://doi.org/10.1016/S0140-6736(16)32381-9
|
[3]
|
Teng, Z., Dong, Y., Zhang, D., et al. (2017) Cerebral Small Vessel Disease and Post-Stroke Cognitive Impairment. International Journal of Neurosci-ence, 127, 824-830. https://doi.org/10.1080/00207454.2016.1261291
|
[4]
|
孙瑞霞, 苏永祥, 孙剑辉. 原子吸收光谱法测定脑血管病患者脑脊液中微量元素[J]. 光谱学与光谱分析, 2006(4): 720-722.
|
[5]
|
Im, D.S., Jeon, J.W., Lee, J.S., et al. (2012) Role of the NMDA Receptor and Iron on Free Radical Production and Brain Damage Following Transient Middle Cerebral Artery Occlusion. Brain Research, 1455, 114-123.
https://doi.org/10.1016/j.brainres.2012.03.025
|
[6]
|
Thomas, C., Mackey, M.M., Diaz, A.A., et al. (2009) Hydrox-yl Radical Is Produced via the Fenton Reaction in Submitochondrial Particles under Oxidative Stress: Implications for Diseases Associated with Iron Accumulation. Redox Report, 14, 102-108. https://doi.org/10.1179/135100009X392566
|
[7]
|
Pantoni, L. (2010) Cerebral Small Vessel Disease: From Patho-genesis and Clinical Characteristics to Therapeutic Challenges. The Lancet Neurology, 9, 689-701. https://doi.org/10.1016/S1474-4422(10)70104-6
|
[8]
|
Schmidt, R., Seiler, S. and Loitfelder, M. (2016) Longitudi-nal Change of Small-Vessel Disease-Related Brain Abnormalities. Journal of Cerebral Blood Flow & Metabolism, 36, 26-39. https://doi.org/10.1038/jcbfm.2015.72
|
[9]
|
Haffner, C., Malik, R. and Dichgans, M. (2016) Genetic Factors in Cerebral Small Vessel Disease and Their Impact on Stroke and Dementia. Journal of Cerebral Blood Flow & Metabo-lism, 36, 158-171.
https://doi.org/10.1038/jcbfm.2015.71
|
[10]
|
Cannistraro, R.J., Badi, M., Eidelman, B.H., et al. (2019) CNS Small Vessel Disease: A Clinical Review. Neurology, 92, 1146-1156. https://doi.org/10.1212/WNL.0000000000007654
|
[11]
|
Hilal, S., Mok, V., Youn, Y.C., et al. (2017) Prevalence, Risk Factors and Consequences of Cerebral Small Vessel Diseases: Data from Three Asian Countries. Journal of Neu-rology, Neurosurgery & Psychiatry, 88, 669-674.
https://doi.org/10.1136/jnnp-2016-315324
|
[12]
|
Wardlaw, J.M. (2001) Prevalence of Cerebral White Matter Lesions in Elderly People: A Population Based Magnetic Resonance Imaging Study: The Rotterdam Scan Study. Journal of Neu-rology, Neurosurgery & Psychiatry, 70, 2-3.
https://doi.org/10.1136/jnnp.70.1.2
|
[13]
|
Poels, M.M., Vernooij, M.W., Ikram, M.A., et al. (2010) Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study. Stroke, 41, S103-S106. https://doi.org/10.1161/STROKEAHA.110.595181
|
[14]
|
封红亮, 张帅美, 罗征进, 等. 严重脑白质疏松症相关因素的病例对照研究[J]. 中风与神经疾病杂志, 2017, 34(4): 324-327.
|
[15]
|
Vernooij, M.W., Van Der Lugt, A., Ikram, M.A., et al. (2008) Prevalence and Risk Factors of Cerebral Microbleeds: The Rotterdam Scan Study. Neurology, 12, 1208-1214. https://doi.org/10.1212/01.wnl.0000307750.41970.d9
|
[16]
|
Klarenbeek, P., Van Oostenbrugge, R.J., Rouhl, R.P., et al. (2013) Ambulatory Blood Pressure in Patients with Lacunar Stroke: Association with Total MRI Bur-den of Cerebral Small Vessel Disease. Stroke, 44, 2995-2999.
https://doi.org/10.1161/STROKEAHA.113.002545
|
[17]
|
Del Bene, A., Ciolli, L., Borgheresi, L., et al. (2015) Is Type 2 Diabetes Related to Leukoaraiosis? An Updated Review. Acta Neurologica Scandinavica, 132, 147-155. https://doi.org/10.1111/ane.12398
|
[18]
|
杜鹃. 血脂、肾小球滤过率和颈动脉斑块与脑小血管病相关性的多因素分析研究[J]. 中国实验诊断学, 2012, 16(6): 1008-1012.
|
[19]
|
蒋胶胶, 杨改清, 徐志强, 等. 脑小血管病发病机制研究进展[J]. 国际脑血管病杂志, 2018, 26(8): 628-631.
|
[20]
|
Khoshnam, S.E., Winlow, W., Farbood, Y., et al. (2017) Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents. Journal of Stroke, 19, 166-187. https://doi.org/10.5853/jos.2016.01368
|
[21]
|
He, W., Goodkind, D. and Kowal, P. (2016) An Aging World: 2015. International Population Reports. Last Modified March, 31.
|
[22]
|
Wardlaw, J.M., Smith, E.E., Biessels, G.J., et al. (2013) Neuroimaging Standards for Research into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration. The Lancet Neurology, 12, 822-838.
https://doi.org/10.1016/S1474-4422(13)70124-8
|
[23]
|
Staals, J., Makin, S.D., Doubal, F.N., et al. (2014) Stroke Subtype, Vascular Risk Factors, and Total MRI Brain Small-Vessel Disease Burden. Neurology, 83, 1228-1234. https://doi.org/10.1212/WNL.0000000000000837
|
[24]
|
黄一宁. 中国脑小血管病诊治共识[J]. 中华神经科杂志, 2015, 48(10): 838-844.
|
[25]
|
Bogdan, A.R., Miyazawa, M., Hashimoto, K., et al. (2016) Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. Trends in Biochemical Sciences, 41, 274-286. https://doi.org/10.1016/j.tibs.2015.11.012
|
[26]
|
Gaasch, J.A., Lockman, P.R., Geldenhuys, W.J., et al. (2007) Brain Iron Toxicity: Differential Responses of Astrocytes, Neurons, and Endothelial Cells. Neurochemical Research, 32, 1196-1208. https://doi.org/10.1007/s11064-007-9290-4
|
[27]
|
Oshiro, S., Morioka, M.S. and Kikuchi, M. (2011) Dysregulation of Iron Metabolism in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis. Advances in Pharmacological and Pharmaceutical Sciences, 2011, Article ID: 378278. https://doi.org/10.1155/2011/378278
|
[28]
|
Pietracupa, S., Martin-Bastida, A. and Piccini, P. (2017) Iron Metabo-lism and Its Detection through MRI in Parkinsonian Disorders: A Systematic Review. Neurological Sciences, 38, 2095-2101.
https://doi.org/10.1007/s10072-017-3099-y
|
[29]
|
Acosta-Cabronero, J., Cardenas-Blanco, A., Betts, M.J., et al. (2017) The Whole-Brain Pattern of Magnetic Susceptibility Perturbations in Parkinson’s Disease. Brain, 140, 118-131. https://doi.org/10.1093/brain/aww278
|
[30]
|
Chen, Q., Chen, Y., Zhang, Y., et al. (2019) Iron Deposition in Par-kinson’s Disease by Quantitative Susceptibility Mapping. BMC Neuroscience, 20, Article No. 23. https://doi.org/10.1186/s12868-019-0505-9
|
[31]
|
Wang, S.M., Fu, L.J., Duan, X.L., et al. (2010) Role of Hepcidin in Murine Brain Iron Metabolism. Cellular and Molecular Life Sciences, 67, 123-133. https://doi.org/10.1007/s00018-009-0167-3
|
[32]
|
Beard, J.L. and Connor, J.R. (2003) Iron Status and Neural Func-tioning. Annual Review of Nutrition, 23, 41-58.
https://doi.org/10.1146/annurev.nutr.23.020102.075739
|
[33]
|
Lonzoff, B. and Brittenham, G.M. (1986) Behavioral Aspects of Iron Deficiency. Progress in Hematology, 14, 23-53.
|
[34]
|
Gebril, O.H., Simpson, J.E., Kirby, J., et al. (2011) Brain Iron Dysregulation and the Risk of Ageing White Matter Lesions. NeuroMolecular Medicine, 13, 289-299. https://doi.org/10.1007/s12017-011-8161-y
|
[35]
|
Fairweather-Tait, S.J., Wawer, A.A., Gillings, R., et al. (2014) Iron Status in the Elderly. Mechanisms of Ageing and Development, 136-137, 22-28. https://doi.org/10.1016/j.mad.2013.11.005
|
[36]
|
Harman, D. (1956) Aging: A Theory Based on Free Radical and Radiation Chemistry. Journal of Gerontology, 11, 298-300. https://doi.org/10.1093/geronj/11.3.298
|
[37]
|
Fredriksson, A., Schroder, N., Eriksson, P., Izquierdo, I. and Archer, T. (2000) Maze Learning and Motor Activity Deficits in Adult Mice Induced by Iron Exposure during a Critical Postnatal Period. Developmental Brain Research, 119, 65-74. https://doi.org/10.1016/S0165-3806(99)00160-1
|
[38]
|
de Lima, M.N., Presti-Torres, J., Caldana, F., Grazziotin, M.M., Scalco, F.S., et al. (2007) Desferoxamine Reverses Neonatal Iron-Induced Recognition Memory Impairment in Rats. European Journal of Pharmacology, 570, 111-114.
https://doi.org/10.1016/j.ejphar.2007.06.002
|
[39]
|
Li, Y., Kim, J., Buckett, P.D., Bohlke, M., Maher, T.J., et al. (2011) Severe Postnatal Iron Deficiency Alters Emotional Behavior and Dopamine Levels in the Prefrontal Cortex of Young Male Rats. The Journal of Nutrition, 141, 2133-2138. https://doi.org/10.3945/jn.111.145946
|
[40]
|
Knight, J.A. (2000) The Biochemistry of Aging. Advances in Clinical Chemistry, 35, 1-62.
https://doi.org/10.1016/S0065-2423(01)35014-X
|
[41]
|
Georgieff, M.K. (2017) Iron Assessment to Protect the De-veloping Brain. The American Journal of Clinical Nutrition, 106, 1588s-1593s. https://doi.org/10.3945/ajcn.117.155846
|
[42]
|
Ward, R.J. and Crichton, R.R. (2019) Ironing out the Brain. In: Es-sential Metals in Medicine: Therapeutic Use and Toxicity of Metal Ions in the Clinic, Met Ions Life Sci, 19. https://doi.org/10.1515/9783110527872-004
|
[43]
|
Manza, P., Wiers, C.E., Shokri-Kojori, E., et al. (2020) Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function. Cerebral Cortex, 30, 5930-5942.
https://doi.org/10.1093/cercor/bhaa167
|
[44]
|
李思瑶, 何慧瑾, 冯晓源, 等. 磁敏感加权成像相位值评估阿尔茨海默病脑内铁沉积[J]. 中国医学影像技术, 2011, 27(4): 698-701.
|
[45]
|
王波, 戴敏方, 王云勇, 等. 帕金森病脑内铁沉积的SWI定量研究[J]. 放射学实践, 2012, 27(11): 1174-1179.
|
[46]
|
Liu, C., Li, C., Yang, J., et al. (2015) Char-acterizing Brain Iron Deposition in Subcortical Ischemic Vascular Dementia Using Susceptibility-Weighted Imaging: An in Vivo MR Study. Behavioural Brain Research, 288, 33-38.
https://doi.org/10.1016/j.bbr.2015.04.003
|
[47]
|
Li, J., Nguyen, T.D., Zhang, Q., et al. (2022) Cerebral Microbleeds Are Associated with Increased Brain Iron and Cognitive Impairment in Patients with Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study. Journal of Magnetic Resonance Imaging, Early View. https://doi.org/10.1002/jmri.28092
|
[48]
|
De La Fuente, M. (2002) Effects of Antioxidants on Immune System Age-ing. European Journal of Clinical Nutrition, 56, S5-S8. https://doi.org/10.1038/sj.ejcn.1601476
|
[49]
|
秦俊法. 微量元素与血管性痴呆(1) [J]. 广东微量元素科学, 2015, 22(2): 60-70.
|
[50]
|
秦俊法, 李增禧. 微量元素与高血压II. 微量元素在血压调控中的作用及机制[J]. 广东微量元素科学, 2003(8): 1-16.
|
[51]
|
Guo, L.N., Yang, Y.Z. and Feng, Y.Z. (2018) Serum and Salivary Ferritin and Hepcidin Levels in Patients with Chronic Periodontitis and Type 2 Diabetes Mellitus. BMC Oral Health, 18, Article No. 63.
https://doi.org/10.1186/s12903-018-0524-4
|
[52]
|
江艳柳, 周农. 脑小血管病血浆铁蛋白及纤维蛋白原与D-二聚体的变化及其意义[J]. 中国基层医药, 2014, 21(10): 1463-1465.
|
[53]
|
徐武平, 张新华, 王桂珍, 等. 血管性痴呆患者红细胞内微量元素的变化[J]. 脑与神经疾病杂志, 2000(6): 346-348.
|
[54]
|
李周玲, 吕雄胜. 血红蛋白对血管性认知功能障碍患者氧化应激分析[J]. 心脑血管病防治, 2018, 18(2): 152-154.
|
[55]
|
Jin, L., Wang, J., Zhao, L., et al. (2011) Decreased Serum Ceruloplasmin Levels Characteristically Aggravate Nigral Iron Deposition in Parkinson’s Disease. Brain, 134, 50-58. https://doi.org/10.1093/brain/awq319
|
[56]
|
Texel, S.J., Zhang, J., Camandola, S., et al. (2011) Ceruloplasmin Deficiency Reduces Levels of Iron and BDNF in the Cortex and Striatum of Young Mice and In-creases Their Vulnerability to Stroke. PLoS One, 6, e25077.
https://doi.org/10.1371/journal.pone.0025077
|
[57]
|
Rhodes, S.L., Buchanan, D.D., Ahmed, I., et al. (2014) Pooled Analysis of Iron-Related Genes in Parkinson’s Disease: Association with Transferrin. Neurobiology of Disease, 62, 172-178. https://doi.org/10.1016/j.nbd.2013.09.019
|
[58]
|
Daglas, M. and Adlard, P.A. (2018) The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease. Frontiers in Neuroscience, 12, 981. https://doi.org/10.3389/fnins.2018.00981
|
[59]
|
Khalaf, S., Ahmad, A.S., Chamara, K., et al. (2018) Unique Proper-ties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma. Journal of Neurotrauma, 36, 43-53.
https://doi.org/10.1089/neu.2017.5617
|
[60]
|
Chen, J., Marks, E., Lai, B., et al. (2013) Iron Accumulates in Hun-tington’s Disease Neurons: Protection by Deferoxamine. PLoS One, 8, e77023. https://doi.org/10.1371/journal.pone.0077023
|
[61]
|
Sripetchwandee, J., Khamseekaew, J., Svasti, S., et al. (2019) Deferiprone and Efonidipine Mitigated Iron-Overload Induced Neurotoxicity in Wild-Type and Thalassemic Mice. Life Sciences, 239, 116878.
https://doi.org/10.1016/j.lfs.2019.116878
|
[62]
|
Skouta, R., Dixon, S.J., Wang, J., et al. (2014) Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models. Journal of the American Chemical Society, 136, 4551-4556. https://doi.org/10.1021/ja411006a
|
[63]
|
Xie, B.S., Wang, Y.Q., Lin, Y., et al. (2019) Inhibition of Fer-roptosis Attenuates Tissue Damage and Improves Long-Term Outcomes after Traumatic Brain Injury in Mice. CNS Neuroscience & Therapeutics, 25, 465-475.
https://doi.org/10.1111/cns.13069
|